BDI reps are on-call for all your emergency and after-hours ordering. Call 1-800-948-9834
to place an order today.
BDI Pharma is a Verified-Accredited Wholesale Distributor one
of 34 active members of the HDMA, and a
member of HISCI. Always rest assured your product is being handled
with the utmost care and professionalism.
Healthcare doesn't stop with humans. See how our level of expertise has reached
the world of our special friends at www.4legPharma.com
Effective April 1, 2012 through June 30, 2012. Visit the Centers for Medicare
& Medicaid Services for more information.
|
|
Heparin
| General Information: Heparin
sodium injection is typically utilized as anticoagulant therapy in
prophylaxis and treatment of venous thrombosis and its extension,
and in low-dose regimen for prevention of postoperative deep venous
thrombosis and pulmonary embolism. For indications, dosing and other information, please refer to the manufacture package insert. |
| |
|
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
|
Sagent |
Heparin Sodium |
1,000 units/mL - 25
x 10mL |
25021-0400-10 |
PI |
MSDS |
|
|
Heparin Sodium |
1,000 units/mL -
25 x 30mL |
25021-0400-30 |
PI |
MSDS |
|
|
Heparin Sodium |
5,000 units/mL -
25 x 1mL |
25021-0402-01 |
PI |
MSDS |
|
|
Heparin Sodium |
5,000 units/mL
- 25 x 10mL |
25021-0402-10 |
PI |
MSDS |
|
|
Heparin Sodium |
10,000 units/mL
- 25 x 1mL |
25021-0403-01 |
PI |
MSDS |
|
|
Heparin Sodium |
10,000 units/mL
- 25 x 4mL |
25021-0403-04 |
PI |
MSDS |
|
|
Heparin Sodium |
20,000 units/mL
-25 x 1mL |
25021-0404-01 |
PI |
MSDS |
|
Pfizer |
Heparin Sodium |
1,000 USP units
per mL 2mL vial |
00069-0043-01 |
PI |
MSDS |
|
| |
|
| Clinical Data:
For any questions or for further information related to Heaprin,
clinical pharmacology, additional indications and usages,
contraindications, warnings, precautions, adverse reactions, dosage,
administration and/or storage of this product, please
contact BDI Pharma or
call 1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|